<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36412591</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-9721</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases (Basel, Switzerland)</Title><ISOAbbreviation>Diseases</ISOAbbreviation></Journal><ArticleTitle>A Multimodal Approach in the Treatment of Persistent Post-COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diseases10040097</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many patients suffer from the consequences of a COVID infection. The so-called long or post-COVID syndrome affects the quality of life of patients and can lead to severe physical impairments. There are currently no suitable therapies for the treatment of long/post-COVID.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 49-year-old patient with post-COVID was admitted to a specialized clinic to carry out a multimodal therapy approach in the event of a therapy-resistant course. In addition to pronounced fatigue, sleep disorders, inner restlessness, and depression were seen in the patients' high levels of suffering. A naturopathic complex therapy including systemic whole-body hyperthermia was carried out. Well-being and physical well-being were recorded using the visual analog scale, and depression was recorded using the Patient Health Questionnaire Depression (PHQ-D). There was close monitoring of the vital parameters, and an evaluation of the therapy result was performed.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">The implementation of a naturopathic complex therapy including systemic whole-body hyperthermia was able to significantly improve the mental state, physical well-being, and mood of the patient. Since there are still no evidence-based therapy recommendations for the treatment of long/post-COVID, clinical research is called upon to intensively deal with this topic and to examine treatment concepts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romeyke</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Informatics and Technology, Institute for Management and Economics in Health Care, UMIT-University of Health Sciences, 6060 Hall in Tirol, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Waldhausklinik Deuringen, Acute Hospital for Internal Medicine, Pain Therapy, Complementary and Individualized Patient Centered Medicine, 86391 Deuringen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diseases</MedlineTA><NlmUniqueID>101636232</NlmUniqueID><ISSNLinking>2079-9721</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">complementary medicine</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">multimodal approach</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">treatment</Keyword><Keyword MajorTopicYN="N">whole-body hyperthermia</Keyword></KeywordList><CoiStatement>The author reports no conflict of interest related to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>7</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36412591</ArticleId><ArticleId IdType="pmc">PMC9680432</ArticleId><ArticleId IdType="doi">10.3390/diseases10040097</ArticleId><ArticleId IdType="pii">diseases10040097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN  COVID-19 Rapid Guideline: Managing the Long Term Effects of COVID-19. 2020.  [(accessed on 25 September 2022)].  Available online:  www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C. Patient-reported outcome measures after COVID-19: A prospective cohort study. Eur. Respir. J. 2020;56:2003276. doi: 10.1183/13993003.03276-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Wang Y., Li X., Ren L., Gu X. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Gubbi S., Koch C.A. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J. Clin. Transl. Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S., Altenberger J., Brose M., Denk-Linnert D.M., Fertl E., G&#xf6;tzinger F., Pellin M.d.l.C.G., Hofbaur B., MPH K.H., Hoffmann-Dorninger R., et al. Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Wien. Klin. Wochenschr. 2021;133:237&#x2013;278. doi: 10.1007/s00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long COVID. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn B.-Y., Moon S., Mok K., Cheon C., Ko Y., Park S., Jang B.-H., Shin Y.-C., Ko S.-G. Use of Traditional, Complementary and Alternative Medicine in Nine Countries: A Cross-Sectional Multinational Survey. Complement. Ther. Med. 2022;71:102889. doi: 10.1016/j.ctim.2022.102889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2022.102889</ArticleId><ArticleId IdType="pubmed">36162719</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO Global Report on Traditional and Complementary Medicine. World Health Organization; Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>Badakhsh M., Dastras M., Sarchahi Z., Doostkami M., Mir A., Bouya S. Complementary and alternative medicine therapies and COVID-19: A systematic review. Rev. Environ. Health. 2021;36:443&#x2013;450. doi: 10.1515/reveh-2021-0012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2021-0012</ArticleId><ArticleId IdType="pubmed">33838089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.H., Jeon S.R., Kang J.W., Kwon S. Complementary and Alternative Medicine for Long COVID: Scoping Review and Bibliometric Analysis. Evid. Based Complement. Altern. Med. 2022;2022:7303393. doi: 10.1155/2022/7303393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7303393</ArticleId><ArticleId IdType="pmc">PMC9371860</ArticleId><ArticleId IdType="pubmed">35966751</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Gou C.-Y., Li X.-M., Song W.-Y., Wang X.-J., Li H.-Y., Li X.-H. Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: A prospective cohort and nested case-control study. Chin. J. Integr. Med. 2021;27:245&#x2013;251. doi: 10.1007/s11655-021-3328-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-021-3328-3</ArticleId><ArticleId IdType="pmc">PMC7857094</ArticleId><ArticleId IdType="pubmed">33534076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi N., Mo Q., Yang S., Qin Y.-X., Chen H., Wu Z.-G., Lan C.-H., Zhang J., Li Y.-L. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. J. Integr. Med. 2021;19:185&#x2013;190. doi: 10.1016/j.joim.2020.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joim.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7719002</ArticleId><ArticleId IdType="pubmed">33349611</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeyke T., Stummer H. Evidence-based complementary and alternative medicine in inpatient care: Take a look at Europe. J. Evid. Based Complement. Altern. Med. 2015;20:87&#x2013;93. doi: 10.1177/2156587214555714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2156587214555714</ArticleId><ArticleId IdType="pubmed">25404750</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomiyama-Miyaji C., Watanabe M., Ohishi T., Kanda Y., Kainuma E., Bakir H.Y., Shen J., Ren H., Inoue M., Tajima K., et al. Modulation of the endocrine and immune systems by well-controlled hyperthermia equipment. Biomed. Res. 2007;28:119&#x2013;125. doi: 10.2220/biomedres.28.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.2220/biomedres.28.119</ArticleId><ArticleId IdType="pubmed">17625344</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt K.L. Effects of Whole Body Hyperthermia on Inflammations and Immune Reactions: Experimental Aspects. Phys. Med. Rehabil. Kurortmed. 2004;14:227&#x2013;235.</Citation></Reference><Reference><Citation>Jimenez C., Melin B., Savourey G., Launay J.C., Alonso A., Mathieu J. Effects of passive hyperthermia versus exercise-induced hyperthermia on immune responses: Hormonal implications. Eur. Cytokine Netw. 2007;18:37&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17823084</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen C.W., Lowry C.A., Mehl M.R., Allen J.J., Kelly K.L., Gartner D.E., Medrano A., Begay T.K., Rentscher K., White J.J., et al. Whole-body hyperthermia for the treatment of major depressive disorder: A randomized clinical trial. JAMA Psychiatry. 2016;73:789&#x2013;795. doi: 10.1001/jamapsychiatry.2016.1031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2016.1031</ArticleId><ArticleId IdType="pubmed">27172277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Dai C., Chen X. Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int. J. Hyperth. 2012;28:735&#x2013;741. doi: 10.3109/02656736.2012.734894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02656736.2012.734894</ArticleId><ArticleId IdType="pubmed">23113543</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeyke T., Scheuer H.C., Stummer H. Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy&#x2014;A prospective controlled study. Clin. Interv. Aging. 2015;10:69. doi: 10.2147/CIA.S74949.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S74949</ArticleId><ArticleId IdType="pmc">PMC4279606</ArticleId><ArticleId IdType="pubmed">25565789</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID syndrome: An insight on its pathogenesis. Vaccines. 2021;9:497. doi: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., Puhan M.A. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Woesner M. What is old is new again: The use of whole-body hyperthermia for depression recalls the medicinal uses of hyperthermia, fever therapy, and hydrotherapy. Curr. Neurbiol. 2019;10:56&#x2013;66.</Citation></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>